• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝内胆管癌中Ki-ras突变与p53蛋白表达:与肿瘤大体形态的关系

Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology.

作者信息

Ohashi K, Nakajima Y, Kanehiro H, Tsutsumi M, Taki J, Aomatsu Y, Yoshimura A, Ko S, Kin T, Yagura K

机构信息

First Department of Surgery, Nara Medical University, Japan.

出版信息

Gastroenterology. 1995 Nov;109(5):1612-7. doi: 10.1016/0016-5085(95)90650-9.

DOI:10.1016/0016-5085(95)90650-9
PMID:7557145
Abstract

BACKGROUND & AIMS: We previously reported that intrahepatic cholangiocarcinomas (ICCs) can be divided into three categories according to their gross appearance with possible links to biological behavior. Ki-ras and p53 gene alterations are thought to be involved in early and late phases of carcinogenesis, respectively. This study was performed to investigate the relationship between the gross appearance and genetic alterations of ICC.

METHODS

We examined 21 patients with ICC. Ki-ras point mutations were assessed by polymerase chain reaction/single-strand conformation polymorphism methods followed by direct DNA sequencing. Expressions of p53 protein were immunohistochemically assessed.

RESULTS

Ki-ras point mutations were found in 10 patients (48%), and expressions of p53 protein were detected in 4 (19%). Applying the gross classification that we previously proposed, Ki-ras mutations were prominent in the periductal extension type (4 of 6; 67%) and the spicula-forming type (6 of 10; 60%). On the other hand, none of the five mass-forming-type tumors harbored Ki-ras mutations. Expressions of p53 protein did not show any clear association with gross appearance.

CONCLUSIONS

Ki-ras gene alterations may be involved in the cholangiocarcinogenesis of periductal extension and spicula-forming but not mass-forming types, suggesting that the underlying processes of development are different.

摘要

背景与目的

我们之前报道过,肝内胆管癌(ICC)可根据大体外观分为三类,这可能与生物学行为相关。Ki-ras和p53基因改变分别被认为参与了致癌作用的早期和晚期阶段。本研究旨在探讨ICC大体外观与基因改变之间的关系。

方法

我们检查了21例ICC患者。通过聚合酶链反应/单链构象多态性方法并随后进行直接DNA测序来评估Ki-ras点突变。通过免疫组织化学评估p53蛋白的表达。

结果

在10例患者(48%)中发现了Ki-ras点突变,在4例(19%)中检测到了p53蛋白的表达。应用我们之前提出的大体分类,Ki-ras突变在导管周围浸润型(6例中的4例;67%)和毛刺形成型(10例中的6例;60%)中较为突出。另一方面,5例肿块形成型肿瘤均未发生Ki-ras突变。p53蛋白的表达与大体外观未显示出任何明确的关联。

结论

Ki-ras基因改变可能参与了导管周围浸润型和毛刺形成型而非肿块形成型的胆管癌发生过程,提示其潜在的发展过程有所不同。

相似文献

1
Ki-ras mutations and p53 protein expressions in intrahepatic cholangiocarcinomas: relation to gross tumor morphology.肝内胆管癌中Ki-ras突变与p53蛋白表达:与肿瘤大体形态的关系
Gastroenterology. 1995 Nov;109(5):1612-7. doi: 10.1016/0016-5085(95)90650-9.
2
Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.肝内胆管癌中p53和K-ras的突变以及APC的杂合性缺失
Lab Invest. 1999 Apr;79(4):477-83.
3
Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.日本和泰国肝内胆管细胞癌中p53肿瘤抑制基因和ras基因家族的突变
Mol Carcinog. 1993;8(4):312-8. doi: 10.1002/mc.2940080415.
4
KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas.胆道上皮内瘤变和肝内胆管癌中的 KRAS 和 GNAS 突变及 p53 过表达。
Cancer. 2013 May 1;119(9):1669-74. doi: 10.1002/cncr.27955. Epub 2013 Jan 18.
5
Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.肝内胆管癌中微卫星不稳定性、K-ras基因突变及p53蛋白过表达的分析
Hepatogastroenterology. 2002 May-Jun;49(45):604-8.
6
Protein expression and genetic alterations of p53 and ras in intrahepatic cholangiocarcinoma.肝内胆管癌中p53和ras的蛋白表达及基因改变
Histopathology. 1999 Sep;35(3):230-40. doi: 10.1046/j.1365-2559.1999.00705.x.
7
High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinomas.
Jpn J Clin Oncol. 1994 Dec;24(6):305-10.
8
p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.人胰腺导管腺癌中的p53、Ki-ras和DNA倍体
Lab Invest. 1996 Jan;74(1):279-89.
9
Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma.肝内胆管癌中的微卫星不稳定性及替代遗传途径
J Hepatol. 2001 Aug;35(2):235-44. doi: 10.1016/s0168-8278(01)00106-4.
10
Alterations of the p53 tumor-suppressor gene and K-ras oncogene in perihilar cholangiocarcinomas from a high-incidence area.
Int J Cancer. 1998 Dec 9;78(6):695-8. doi: 10.1002/(sici)1097-0215(19981209)78:6<695::aid-ijc5>3.0.co;2-8.

引用本文的文献

1
Intraductal papillary neoplasm of the bile duct: Cytomorphologic and molecular features.胆管内乳头状肿瘤:细胞形态学和分子特征。
Cancer Cytopathol. 2023 Jan;131(1):37-49. doi: 10.1002/cncy.22637. Epub 2022 Aug 30.
2
Up-to-Date Pathologic Classification and Molecular Characteristics of Intrahepatic Cholangiocarcinoma.肝内胆管癌的最新病理分类及分子特征
Front Med (Lausanne). 2022 Mar 31;9:857140. doi: 10.3389/fmed.2022.857140. eCollection 2022.
3
Cystic biliary tumors of the liver: diagnostic criteria and common pitfalls.
肝囊性胆管肿瘤:诊断标准及常见误区。
Hum Pathol. 2021 Jun;112:70-83. doi: 10.1016/j.humpath.2020.12.010. Epub 2020 Dec 28.
4
Evaluation of positive ductal margins of biliary tract cancer in intraoperative histological examination.术中组织学检查中胆管癌阳性切缘的评估
Oncol Lett. 2018 Nov;16(5):6677-6684. doi: 10.3892/ol.2018.9479. Epub 2018 Sep 21.
5
Potential candidate treatment agents for targeting of cholangiocarcinoma identified by gene expression profile analysis.通过基因表达谱分析确定的用于靶向胆管癌的潜在候选治疗药物。
Biomed Rep. 2018 Jul;9(1):42-52. doi: 10.3892/br.2018.1101. Epub 2018 May 22.
6
Macroscopic types of intrahepatic cholangiocarcinoma and the eighth edition of AJCC/UICC TNM staging system.肝内胆管癌的大体类型与美国癌症联合委员会/国际抗癌联盟(AJCC/UICC)第八版TNM分期系统
Oncotarget. 2017 Sep 15;8(60):101165-101174. doi: 10.18632/oncotarget.20932. eCollection 2017 Nov 24.
7
Improved Postoperative Survival for Intraductal-Growth Subtype of Intrahepatic Cholangiocarcinoma.肝内胆管癌导管内生长亚型术后生存率提高
Am Surg. 2016 Nov 1;82(11):1133-1139.
8
Aberrant activation of Notch signaling in extrahepatic cholangiocarcinoma: clinicopathological features and therapeutic potential for cancer stem cell-like properties.肝外胆管癌中Notch信号通路的异常激活:临床病理特征及对癌症干细胞样特性的治疗潜力
BMC Cancer. 2016 Nov 7;16(1):854. doi: 10.1186/s12885-016-2919-4.
9
Intrahepatic Biliary Intraductal Oncocytic Papillary Neoplasm/Carcinoma: First Reported Case in Australia and Literature Review.肝内胆管导管内嗜酸性乳头状肿瘤/癌:澳大利亚首例报告病例及文献综述
Radiol Case Rep. 2015 Dec 7;2(3):95. doi: 10.2484/rcr.v2i3.95. eCollection 2007.
10
A novel mouse model of intrahepatic cholangiocarcinoma induced by liver-specific Kras activation and Pten deletion.一种通过肝脏特异性Kras激活和Pten缺失诱导的肝内胆管癌新型小鼠模型。
Sci Rep. 2016 Apr 1;6:23899. doi: 10.1038/srep23899.